Federal Court Rules FDA Restrictions on Abortion Pill Mifepristone Are Unjustified and Must Be Reconsidered

A federal court in Virginia has ruled that the Food and Drug Administration's (FDA) restrictions on the abortion pill mifepristone are 'unjustified and baseless' and ordered the agency to reconsider them. The court, in the case of Whole Woman's Health Alliance v. FDA, stated that the FDA disregarded scientific evidence demonstrating mifepristone's safety without restrictive regulations. U.S. District Judge Robert S. Ballou called the restrictions 'arbitrary and capricious,' emphasizing the FDA's consistent findings over 25 years that mifepristone is safe and effective. This decision comes amid ongoing efforts to restrict abortion pills nationwide.